 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO  EXISTING LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *hb0939*      
HOUSE BILL 939  
O1, J1    5lr2021  
    CF SB 674  
By: Delegates Pena –Melnyk, Acevero, Bagnall, Cullison, and Terrasa  Terrasa , 
Bhandari, Guzzone, Hill, S.  Johnson, Kaiser, Kerr, Lopez, Martinez, 
Rosenberg, Taveras, White  Holland, Woods, and Woorman  
Introduced and read first time: January 31, 2025  
Assigned to: Health and Government Operations  
Committee Report: Favorable with  amendments  
House action: Adopted  
Read second time: February 25, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Maryland Commission for Women – Maryland Collaborative to Advance 2 
Implementation of Coverage of Over –the–Counter Birth Control  3 
 
FOR the purpose of requiring the Maryland Commission for Women to establish the 4 
Maryland Collaborative to Advance Implementation of Coverage of  5 
Over –the–Counter Birth Control to study access to over –the–counter birth control; 6 
and generally relating to cov erage of over –the–counter birth control.  7 
 
Preamble  8 
 
 WHEREAS, Access to birth control is essential to reproductive freedom and 9 
autonomy; and  10 
 
 WHEREAS, Increasing access to over –the–counter birth control is a critical strategy 11 
in empowering people who have been unable to access birth control because of challenges 12 
in navigating the health care system; and  13 
 
 WHEREAS, Maryland was the first state to require coverage of over –the–counter 14 
birth control with the enactment of the Contraceptive Equity Act of 201 6; and  15 
 
 WHEREAS, 2.7 million Marylanders now have coverage of over –the–counter birth 16 
control through a State –regulated private plan, the Maryland Medical Assistance Program, 17 
or the State Employee and Retiree Health and Welfare Benefits Program; and  18 
2 HOUSE BILL 939   
 
  
 WHER EAS, On July 13, 2023, the federal Food and Drug Administration expanded 1 
the number of over –the–counter birth control options with the approval of the first daily 2 
birth control pill for over –the–counter use; and  3 
 
 WHEREAS, Maryland can continue to lead the  nation in ensuring over –the–counter 4 
birth control access by establishing a consumer –focused implementation collaborative to 5 
support collaboration among consumer organizations, industry stakeholders, and State 6 
agencies; now, therefore,  7 
 
 SECTION 1. BE IT E NACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 8 
That:  9 
 
 (a) The Maryland Commission for Women in the Department of Human Services 10 
shall establish the Maryland Collaborative to Advance Implementation of Coverage of 11 
Over –the–Counter Birth Control.  12 
 
 (b) The Coll aborative consists of the following members:  13 
 
  (1) one representative of the Maryland Insurance Administration, 14 
designated by the Commissioner of the Maryland Insurance Administration;  15 
 
  (2) two representatives of the Maryland Department of Health, desig nated 16 
by the Secretary of Health, of whom:  17 
 
   (i) one shall be a representative of the Maryland Medical Assistance 18 
Program; and  19 
 
   (ii) one shall be a representative of public health;  20 
 
  (3) one representative of the Department of Budget and Management w ith 21 
expertise in the State Employee and Retiree Health and Welfare Benefits Program, 22 
designated by the Secretary of Budget and Management;  23 
 
  (4) one representative of the Maryland Health Benefit Exchange, 24 
designated by the Executive Director of the Maryla nd Health Benefit Exchange; and  25 
 
  (5) the following members, appointed by the Secretary of Human Services:  26 
 
   (i) one representative of Ibis Reproductive Health;  27 
 
   (ii) one representative of the National Health Law Program;  28 
 
   (iii) one representativ e of the American Society for Emergency 29 
Contraception;  30 
 
 HOUSE BILL 939  3 
 
    (iv) two representatives of Maryland –based reproductive justice 1 
organizations;  2 
 
   (v) one representative of Advocates for Youth;  3 
 
   (vi) one representative of the Maryland Retailers Alliance;  4 
 
   (vii) one representative of the Maryland Association of Chain Drug 5 
Stores;  6 
 
   (viii)  one representative of the Independent Pharmacies of Maryland;  7 
 
   (ix) one representative of the Maryland Pharmacist Association;  8 
 
   (x) one representative of the Leagu e of Life and Health Insurers of 9 
Maryland;  10 
 
   (xi) one representative of a pharmacy benefits manager;  11 
 
   (xii) one representative of the Maryland Managed Care Organization 12 
Association;  13 
 
   (xiii)  one representative of a public higher education institut ion that 14 
provides student health insurance; and  15 
 
   (xiv) one representative of the Consumer Health Information Hub at 16 
the University of Maryland School of Public Health.  17 
 
 (c) The chair of the Maryland Commission for Women shall designate the chair 18 
of the  Collaborative.  19 
 
 (d) The Maryland Commission for Women shall provide staff for the 20 
Collaborative.  21 
 
 (e) A member of the Collaborative:  22 
 
  (1) may not receive compensation as a member of the Collaborative; but  23 
 
  (2) is entitled to reimbursement for expenses under the Standard State 24 
Travel Regulations, as provided in the State budget.  25 
 
 (f) The purpose of the Collaborative is to study and make recommendations to 26 
advance access to over –the–counter birth control through:  27 
 
  (1) implementation of State c overage requirements for over –the–counter 28 
birth control at pharmacies;  29 
 
4 HOUSE BILL 939   
 
   (2) advancement of point –of–sale coverage options at retail counters, 1 
virtual retail platforms, and vending machines;  2 
 
  (3) identification of public health initiatives to increase a ccess to  3 
over–the–counter birth control for individuals who:  4 
 
   (i) do not have over –the–counter birth control coverage; or  5 
 
   (ii) cannot access over –the–counter birth control coverage; and  6 
 
  (4) enhancement of education and engagement of consumers, health care 7 
practitioners, public health and community programs, and health care industry 8 
stakeholders.  9 
 
 (g) The Collaborative shall:  10 
 
  (1) study:  11 
 
   (i) responses to the request for information on over –the–counter 12 
coverage of preventive services publi shed on October 4, 2023, from the U.S. Department of 13 
Labor, the U.S. Department of the Treasury, and the U.S. Department of Health and 14 
Human Services;  15 
 
   (ii) responses to the proposed rule on over –the–counter coverage 16 
issued by the U.S. Department of Hea lth and Human Services on October 21, 2024;  17 
 
   (iii) the report developed in consultation with policy experts in states 18 
with over –the–counter coverage laws and published by Ibis Reproductive Health on 19 
November 4, 2024, titled “Free the Pill and Cover it Too: Strategies for Making OTC 20 
Coverage Work in the Real World”; and  21 
 
   (iv) other reports and materials on implementing coverage for  22 
over–the–counter birth control; and  23 
 
  (2) make recommendations on its findings.  24 
 
 (h) The Collaborative may consult wit h: 25 
 
  (1) health professional associations and other  organizations with expertise 26 
in advancing equitable access to birth control for all communities;  27 
 
  (2) retailers, independent and chain pharmacies, pharmacists, online retail 28 
platforms, wellness vending  machine companies, and any other entity involved in providing 29 
over–the–counter contraception;  30 
 
  (3) insurers, managed care organizations, pharmacy benefits managers, 31 
entities that administer cards for health savings accounts or flexible spending accounts , 32 
 HOUSE BILL 939  5 
 
 and any other organizations involved in administering coverage of over –the–counter 1 
contraception; and  2 
 
  (4) community health centers, local health departments, and  3 
community –based organizations that support communities that have historically not been 4 
engaged with the health care system.  5 
 
 (i) (1) On or before January 1, 2026, the Collaborative shall submit an interim 6 
report of its findings and recommendations to the Governor and, in accordance with §  7 
2–1257 of the State Government Article, the General Assembly.  8 
 
  (2) On or before December 1, 2027, the Collaborative shall submit a final 9 
report of its findings and recommendations to the Governor and, in accordance with §  10 
2–1257 of the State Government Article, the General Assembly.  11 
 
 SECTION 2. AND BE I T FURTHER ENACTED, That this Act shall take effect July 12 
1, 2025. It shall remain effective for a period of 3 years and, at the end of June 30, 2028, 13 
this Act, with no further action required by the General Assembly, shall be abrogated and 14 
of no further for ce and effect.  15 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  
________________________________ ________________________________ ________________   
                 President of the Senate.  